Ribo Life Science Lists on HKEX, Raising HKD 1.8 Billion in siRNA IPO January 9, 2026 by Mathieu Maurice Ribo Life Science Co., Ltd, a pioneer in the development of small interfering RNA (siRNA) therapies, has successfully debuted on the Main Board of the Hong Kong Stock Exchange. This …
